We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$1.5B
AUM Growth
+$242M
Cap. Flow
+$178M
Cap. Flow %
11.93%
Top 10 Hldgs %
18.61%
Holding
7,153
New
1,586
Increased
2,321
Reduced
1,709
Closed
1,363

Sector Composition

Rank Sector Weight
1 Communication Services 6.61%
2 Healthcare 6.55%
3 Technology 6.45%
4 Consumer Discretionary 4.54%
5 Financials 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
476
Ford
F
$57.5B
$559K 0.04%
+44,503
New +$587K
WNR
477
DELISTED
Western Refining Inc
WNR
$555K 0.04%
26,927
+15,691
+140% +$368K
HPE icon
478
Hewlett Packard
HPE
$63.7B
$554K 0.04%
52,214
+38,450
+279% +$391K
SHOP icon
479
Shopify
SHOP
$154B
$554K 0.04%
180,300
+35,870
+25% +$105K
INSY
480
DELISTED
Insys Therapeutics, Inc.
INSY
$554K 0.04%
42,884
+40,960
+2,129% +$597K
ZSL icon
481
ProShares UltraShort Silver
ZSL
$88.6M
$551K 0.04%
109
-48
-31% -$314K
IMS
482
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$550K 0.04%
+21,715
New +$557K
ARCC icon
483
Ares Capital
ARCC
$13.5B
$548K 0.04%
38,641
+35,054
+977% +$520K
ENDP
484
PUT
DELISTED
Endo International plc
ENDP
$547K 0.04%
2,644
+1,912
+261% +$39.6K
ABBV icon
485
CALL
AbbVie
ABBV
$448B
$544K 0.04%
2,344
+648
+38% +$39.5K
NTES icon
486
CALL
NetEase
NTES
$77.6B
$544K 0.04%
1,565
-765
-33% -$23.8K
WFC icon
487
PUT
Wells Fargo
WFC
$262B
$544K 0.04%
4,685
+2,531
+118% +$123K
TIF
488
PUT
DELISTED
Tiffany & Co.
TIF
$544K 0.04%
891
+650
+270% +$43.2K
RTN
489
CALL
DELISTED
Raytheon Company
RTN
$543K 0.04%
592
-396
-40% -$51.6K
AAP icon
490
Advance Auto Parts
AAP
$3.35B
$542K 0.04%
+3,354
New +$518K
BHC icon
491
CALL
Bausch Health
BHC
$1.7B
$539K 0.04%
8,522
+799
+10% +$22.6K
DVAX
492
DELISTED
Dynavax Technologies
DVAX
$539K 0.04%
36,972
+7,525
+26% +$129K
BFH icon
493
Bread Financial
BFH
$4.12B
$538K 0.04%
+3,442
New +$573K
CRM icon
494
PUT
Salesforce
CRM
$133B
$536K 0.04%
3,025
+2,046
+209% +$161K
RCL icon
495
PUT
Royal Caribbean
RCL
$76.7B
$535K 0.04%
626
+308
+97% +$23.6K
MDVN
496
DELISTED
MEDIVATION, INC.
MDVN
$534K 0.04%
+8,862
New +$502K
AMGN icon
497
CALL
Amgen
AMGN
$198B
$532K 0.04%
1,012
-801
-44% -$125K
SNBR
498
DELISTED
Sleep Number
SNBR
$532K 0.04%
24,896
+16,037
+181% +$350K
UA icon
499
CALL
Under Armour Class C
UA
$3.02B
$532K 0.04%
+1,475
New +$54.4K
CPRI icon
500
PUT
Capri Holdings
CPRI
$1.86B
$527K 0.04%
920
+488
+113% +$24K

Similar funds

Simplex Trading's Q2 2016 Portfolio in Review

As of Q2 2016, Simplex Trading held 7,153 positions worth $1.5B, up 19% from $1.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Simplex Trading deployed $178M of net new capital in Q2 2016, opening 1,586 new positions and adding to 2,321 existing holdings. Its largest new stake was Biogen: 56,467 shares worth $13.7M.

By sector, the portfolio is most concentrated in Communication Services at 6.6% of assets, down from 6.9% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Broadcom, an estimated $36.7M trimmed.

  • Simplex Trading's largest Q2 2016 buy was Biogen: 56,467 shares worth $13.7M.
  • Simplex Trading added most to LinkedIn Corporation in Q2 2016, an estimated $21.4M increase.
  • Simplex Trading's biggest Q2 2016 reduction was Broadcom, cutting an estimated $36.7M.
  • Simplex Trading fully exited Alphabet (Google) Class C in Q2 2016, selling an estimated $20.1M.
  • Simplex Trading's ten largest holdings make up 19% of its $1.5B portfolio in Q2 2016.
  • Simplex Trading opened 1,586 new positions and closed 1,363 in Q2 2016.
  • Simplex Trading's portfolio value rose 19% quarter-over-quarter to $1.5B.

Based on Simplex Trading's 13F filing for Q2 2016, filed 18 Jul 2016.